Status:
RECRUITING
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
First Affiliated Hospital, Sun Yat-Sen University
First People's Hospital of Foshan
Conditions:
Nasopharyngeal Carcinoma
Endoscopic Surgery
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Nasopharyngeal carcinoma (NPC) is most prevalent in eastern Asia, with the highest incidence reported among the Cantonese population from the province of Guangdong. Radiotherapy is the cornerstone of ...
Eligibility Criteria
Inclusion
- Previously untreated, biopsy-proven World Health Organization (WHO) types II or III NPC; Stage I disease (American Joint Committee on Cancer 7th edition); Between 18 and 70 years old; Adequate bone marrow, liver and renal function; Satisfactory performance status: a score of 0 or 1 using the Eastern Cooperative Oncology Group System; Patients provided signed informed consent.
Exclusion
- Evidence of relapse or distant metastasis; History of prior malignancy or previous treatment for NPC; The presence of uncontrolled life-threatening diseases; The investigator considered the patient unable to complete the study.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT03353467
Start Date
October 1 2017
End Date
October 1 2028
Last Update
June 3 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060
2
The First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China, 510080
3
The First People's Hospital of Foshan
Guangzhou, Guangdong, China, 528000
4
Zhongshan People's Hospital
Zhongshan, Guangdong, China, 528403